title: Disseminated Mycobacterium avium subspecies infection in a cat.
authors.affiliation: Scanelis, 9 allée Charles Cros, Colomiers, France. delphine.riviere@scanelis.com
authors.forename: Delphine
authors.initials: D
authors.lastname: Rivière
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Pingret
authors.forename: Mélanie
authors.initials: M
authors.lastname: Etievant
authors.forename: Aurélie
authors.initials: A
authors.lastname: Jechoux
authors.forename: Didier
authors.initials: D
authors.lastname: Lanore
authors.forename: Isabelle
authors.initials: I
authors.lastname: Raymond-Letron
authors.forename: Corine
authors.initials: C
authors.lastname: Boucraut-Baralon
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002371:Cat Diseases / Q000188:drug therapy / Q000382:microbiology*; D002415:Cats; D002440:Cefoxitin / Q000009:adverse effects; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000662:veterinary; D017809:Fatal Outcome; D024841:Fluoroquinolones / Q000009:adverse effects; D008297:Male; D009162:Mycobacterium avium / Q000145:classification* / Q000302:isolation & purification; D012293:Rifampin / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D002440:Cefoxitin; C080260:marbofloxacin; D012293:Rifampin